Cann Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Peter Koetsier

Chief executive officer

AU$442.2k

Total compensation

CEO salary percentage	35.0%
CEO tenure	1.3yrs
CEO ownership	n/a
Management average tenure	less than a year
Board average tenure	2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Peter Koetsier's remuneration changed compared to Cann Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-AU$29m
Sep 30 2023	n/a	n/a	-AU$32m
Jun 30 2023	AU$442k	AU$155k	-AU$34m

Compensation vs Market: Peter's total compensation ($USD287.68K) is below average for companies of similar size in the US market ($USD668.06K).

Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.

CEO

Peter Koetsier

1.3yrs

Tenure

AU$442,188

Compensation

Mr. Peter Koetsier is Chief Executive Officer of Cann Group Limited from January 16, 2023. Mr. Koetsier brings to Cann more than 30 years of general management, marketing and commercial leadership roles wi...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Peter Koetsier	Chief Executive Officer	1.3yrs	AU$442.19k	no data
Tony Di Pietro	CFO & Joint Company Secretary	no data	no data	no data
Steven Notaro	Head of Legal and Regulatory Affairs & Joint Company Secretary	less than a year	AU$204.01k	no data

0.3yrs

Average Tenure

Experienced Management: CNGG.F's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Douglas Rathbone	Independent Non-Executive Director	9.1yrs	AU$65.00k	0.82% A$ 145.1k
Julian Chick	Non-Executive Chairman	1.5yrs	AU$46.39k	no data
Jennifer Pilcher	Non-Executive Director	3.6yrs	AU$80.00k	0.029% A$ 5.0k
Robert Barnes	Non-Executive Director	1.6yrs	AU$49.81k	no data

2.6yrs

Average Tenure

Experienced Board: CNGG.F's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Cann Group Management

Management criteria checks 1/4

Key information

Recent management updates

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Cann Group Limited Announces Chief Executive Officer Changes

Cann Group Limited Appoints Julian John Chick as Director

Cann Group Limited Announces Resignation of Peter Crock as CEO

Recent updates

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.3756 million.

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.3756 million.

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 11.658446 million.

Cann Group Limited Provides Revenue Guidance for the Year Ended June 30, 2023

Cann Group Limited Announces Preliminary Results from Their Phase 3 Clinical Trail

Cann Group Limited Announces Chief Executive Officer Changes

Cann Group Limited Announces Final Clinical Trial Participant Completes Study

Cann Group Limited Appoints Julian John Chick as Director

Cann Group Limited Announces Resignation of Peter Crock as CEO

Cann Group Limited Meets its Enrolment Target for Phase III Clinical Trial of Low-Dose Satipharm CBD Capsules for Short-Term Sleep Disturbance

Cann Group Limited Announces Executive Changes

Cann Group Limited Appoints Robert Barnes & Julian Chick to the Board

Cann Group Limited Announces Resignation of John Sharman as Director

Cann Group Limited, Annual General Meeting, Oct 25, 2022

Cann Group Limited Announce Therapeutic Goods Administration Grants Cann GMP License to Manufacture Therapeutic Goods

Cann Group Limited Receives Second Payment from Victorian Government's Regional Jobs Fund Program

Office of Drug Control Grants Permit for Manufacture of Medicinal Cannabis Products to Cann Group Limited

Cann Group Limited Announces Resignation of Mr. Geoffrey Pearce as Non-Executive Director

Cann Group Limited Announces Cann to Begin Recruitment for CBD Phase 3 Clinical Trial

Rua Bioscience Limited (NZSE:RUA) agreed to acquire 8.36% stake in Zalm Therapeutics Ltd from Cann Group Limited (ASX:CAN) for NZD 10 million.

Cann Group Limited Revises Revenue Guidance for the Year 2021

Cann Group Limited (ASX:CAN) completed the acquisition of Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT)

Cann Group Limited, Olivia Newton-John Cancer Research Institute and Austin Health Partnered in A Clinical Tria to Assess Medicinal Cannabis for Symptom Management in People with Advanced Cancer

Cann Group Limited (ASX:CAN) entered into a definitive sale agreement to acquire Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT).

Cann Group Limited (ASX:CAN) signed a share sale agreement to acquire Satipharm Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for CAD 4 million.

Australis Capital Inc. and Cann Group Limited Sign Agreement

Cann Group Limited Receives Initial 19,000 Unit Order for Europe

An unknown buyers acquired 11.84% stake in Cann Group Limited (ASX:CAN) from Aurora Cannabis Inc. (TSX:ACB).

Cann Group Limited(ASX:CAN) dropped from S&P Global BMI Index

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 25.9 million.

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 14.3 million.

Cann Group Limited(ASX:CAN) dropped from S&P/ASX All Ordinaries Index

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure